PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDairy Crest Regulatory News (DCG)

  • There is currently no data for DCG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

9 Feb 2017 07:00

RNS Number : 3784W
Dairy Crest Group PLC
09 February 2017
 

 

9 February 2017

 

Dairy Crest Group plc ("Dairy Crest")

 

Interim Management Statement

 

Dairy Crest is today issuing its Interim Management Statement for the nine months ended 31 December 2016.

 

Outlook

 

The outlook for the full year remains in line with our expectations.

 

Branded performance

 

Our key brands have continued to perform well. Clover, Frylight and Country Life have all grown volumes in the first nine months of the year and have taken significant share in their respective markets. As predicted, Cathedral City performance improved in the third quarter.

 

Overall, in the first nine months of the year the combined volumes of Cathedral City, Country Life, Clover and Frylight are in line with the same period last year.

 

Innovation and brand building continues to be at the heart of what we do. Clover and Frylight have both seen new packaging launches during the quarter and Frylight has been supported by a new TV advertising campaign over the last six weeks. In January 2017, Clover won the spreads category "Product of the Year 2017" award in the world's largest consumer survey award for product innovation. This is a testimony to the work we undertook to remove artificial ingredients from Clover. Furthermore, in October 2016 Frylight won the Institute of Grocery and Distribution Health and Wellness award. We will continue to invest in innovation and marketing across our key brands through 2017.

 

Functional Ingredients

 

Production of demineralised whey powder and galacto-oligosaccharide ("GOS"), both ingredients for the growing global infant formula market, continues to develop well at our factory in Davidstow. There have been significant improvements in the percentage level of demineralised whey hitting the important infant formula grade. We remain confident that this will continue to rise and that we will hit our target of over 80% by 31 March 2017.

 

On 21 December 2016, Dairy Crest announced that it had entered into a research partnership with Danisco Animal Nutrition, part of DuPont, to further explore the potential uses of GOS in poultry and swine. If successful, this work would help to broaden the potential market for GOS beyond infant formula.

 

Balance sheet

 

We have seen further milk cost inflation since the half year and have now announced increases in the price paid to farmers of 8.28 pence per litre since June 2016. This represents an increase of 38%. Furthermore, market prices for cream have remained high after more than doubling in the first half of the year. The cream price determines the input costs for our butter business. These movements inevitably result in a short-term working capital outflow and, as a result, we now expect year end net debt to be somewhat higher than 31 March 2016.

 

New auditor appointment

 

The Board has approved the appointment of Deloitte as external auditor for the year commencing 1 April 2017. This appointment will be subject to shareholder approval at the 2017 Annual General Meeting. The Group's current auditor, Ernst & Young, is retiring by rotation and will carry out the audit for the year ending 31 March 2017. The Board would like to thank Ernst & Young for their contribution to the business over many years.

 

 

 

Mark Allen, Chief Executive of Dairy Crest, commented:

 

"The outlook for the full year remains in line with our expectations.

 

The business has continued to make progress during the quarter. Our brands have performed well supported by successful innovation and brand investment. I'm particularly pleased to see the improvement in Cathedral City's performance.

 

At the new Davidstow functional ingredients facility we are seeing significant improvement in the percentage level of demineralised whey meeting infant formula grade. This is important in maximising future opportunities in this market.

 

The announcement of the partnership with Danisco Animal Nutrition marks a further significant step in the development of GOS beyond infant formula. This has exciting potential opportunities for the future."

 

 

Dairy Crest will issue its Preliminary Results for the year ending 31 March 2017 on 18 May 2017.

 

 

 

For further information, please contact:

Dairy Crest

Alistair Smith

01372 472236

Dairy Crest

Tom Atherton

01372 472264

Brunswick

Mike Smith

0207 404 5959

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQVLFBDLFBBBX
Date   Source Headline
2nd Feb 20124:53 pmRNSHolding(s) in Company
2nd Feb 20127:00 amRNSInterim Management Statement
1st Feb 20129:46 amRNSTotal Voting Rights
11th Jan 20125:15 pmRNSDirector/PDMR Shareholding
30th Dec 201110:10 amRNSTotal Voting Rights
30th Nov 20118:54 amRNSTotal Voting Rights
10th Nov 20117:00 amRNSInterim Results Announcement
31st Oct 20118:14 amRNSTotal Voting Rights
14th Oct 20117:00 amRNSDebt refinancing completed
10th Oct 201111:22 amRNSNon Executive Director Appointment
4th Oct 20115:35 pmRNSHolding(s) in Company
4th Oct 20115:33 pmRNSHolding(s) in Company
30th Sep 20118:15 amRNSTotal Voting Rights
19th Sep 20117:00 amRNSTRADING UPDATE
31st Aug 201110:43 amRNSTotal Voting Rights & Capital
8th Aug 20119:29 amRNSAnnual Information Update
2nd Aug 201110:25 amRNSDirector/PDMR Shareholding
2nd Aug 201110:21 amRNSDirector/PDMR Shareholding
1st Aug 20115:21 pmRNSDirector/PDMR Shareholding
29th Jul 20115:07 pmRNSTotal Voting Rights
29th Jul 20115:01 pmRNSDirector/PDMR Shareholding
19th Jul 20116:15 pmRNSResult of AGM
19th Jul 20117:00 amRNSAGM Statement and IMS
30th Jun 201110:10 amRNSTotal Voting Rights
24th Jun 20114:39 pmRNSDirector/PDMR Shareholding
31st May 201110:57 amRNSTotal Voting Rights
31st May 201110:13 amRNSExecutive Director Notification
19th May 20117:00 amRNSFinal Results
12th May 20115:36 pmRNSDirectorate Change
11th May 20119:56 amRNSHolding(s) in Company
11th May 20119:51 amRNSHolding(s) in Company
3rd May 20116:04 pmRNSTotal Voting Rights
1st Apr 20114:46 pmRNSHolding(s) in Company
31st Mar 201111:48 amRNSTotal Voting Rights
31st Mar 20117:00 amRNSTrading statement
28th Feb 201112:37 pmRNSTotal Voting Rights
4th Feb 20117:00 amRNSInterim Management Statement
2nd Feb 201110:01 amRNSHolding(s) in Company
31st Jan 201111:53 amRNSTotal Voting Rights
13th Jan 201112:16 pmRNSDirector/PDMR Shareholding
31st Dec 20109:58 amRNSTotal Voting Rights
1st Dec 201011:26 amRNSDirector/PDMR Shareholding
30th Nov 201012:15 pmRNSTotal Voting Rights
30th Nov 201011:03 amRNSHolding(s) in Company - Amendment
29th Nov 20106:30 pmRNSHolding(s) in Company
11th Nov 20107:00 amRNSHalf Yearly Report
10th Nov 20107:51 amRNSNon-Executive Director Notification
1st Nov 201010:07 amRNSTotal Voting Rights
4th Oct 201012:10 pmRNSNotification of Board change
1st Oct 20109:16 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.